MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,994,320 | +199.4% | 11,213 | +159.4% | 0.02% | +142.9% |
| Q4 2023 | $1,000,024 | -77.8% | 4,322 | -76.8% | 0.01% | -75.0% |
| Q1 2023 | $4,508,216 | +30.5% | 18,609 | +56.4% | 0.03% | +40.0% |
| Q4 2022 | $3,454,265 | +398.5% | 11,901 | +11.6% | 0.02% | +400.0% |
| Q3 2022 | $693,000 | +161.5% | 10,663 | +188.2% | 0.00% | +100.0% |
| Q2 2022 | $265,000 | -54.2% | 3,700 | -37.3% | 0.00% | -60.0% |
| Q1 2022 | $579,000 | -59.4% | 5,901 | -65.0% | 0.01% | -64.3% |
| Q4 2021 | $1,427,000 | +786.3% | 16,844 | +733.9% | 0.01% | +600.0% |
| Q3 2021 | $161,000 | -94.0% | 2,020 | -92.7% | 0.00% | -93.3% |
| Q2 2021 | $2,695,000 | +58.6% | 27,664 | +81.0% | 0.03% | +30.4% |
| Q4 2020 | $1,699,000 | +101.1% | 15,281 | +114.8% | 0.02% | +76.9% |
| Q3 2020 | $845,000 | +136.7% | 7,113 | +125.8% | 0.01% | +116.7% |
| Q2 2020 | $357,000 | +123.1% | 3,150 | +31.2% | 0.01% | +50.0% |
| Q1 2020 | $160,000 | -87.0% | 2,400 | -82.2% | 0.00% | -82.6% |
| Q4 2019 | $1,230,000 | +101.0% | 13,497 | +90.3% | 0.02% | +91.7% |
| Q3 2019 | $612,000 | +114.7% | 7,093 | +161.2% | 0.01% | +140.0% |
| Q2 2019 | $285,000 | +53.2% | 2,716 | +82.5% | 0.01% | -16.7% |
| Q1 2019 | $186,000 | +33.8% | 1,488 | +20.7% | 0.01% | -14.3% |
| Q4 2018 | $139,000 | -67.3% | 1,233 | -37.9% | 0.01% | -69.6% |
| Q3 2018 | $425,000 | +248.4% | 1,986 | +49.7% | 0.02% | +283.3% |
| Q4 2017 | $122,000 | – | 1,327 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |